Eric Smith, PharmD is currently a Senior Director, Safety Evaluation and Risk Management (SERM) at TESARO, A GSK Company where he provides scientific expertise in the safety evaluation and risk management of key assets in clinical development and the post-marketing setting. Prior to this current position, he worked over 25 years in the pharmaceutical industry and served as a Pharmacovigilance Science Director at AstraZeneca and a Director and Safety Development Leader within the SERM group of the Global Clinical Safety and Pharmacovigilance department at GlaxoSmithKline. Eric earned his Bachelor of Science and Doctor of Pharmacy degrees from the University of North Carolina at Chapel Hill.